Cylindrocarcinoma: Could Mohs Surgery Be the Clear-Cut Winner? Cylindrocarcinoma—a rare malignant offshoot of benign cylindromas—poses a surgical challenge due to its potential for recurrence and metastasis. While traditional excision has…
Read More
Explore JDDonline If you’re on the hunt for expert-led, handpicked resources on psoriasis, you’re in the right place. Whether you're brushing up on the latest treatment insights or looking for…
Read More
A Fern with Far-Reaching Potential: The Role of Polypodium Leucotomos Extract in Dermatology From photoaging to pigmentary disorders, Polypodium leucotomos extract (PLE)—a botanical with notable photoprotective and anti-inflammatory properties—has emerged…
Read More
Did you miss it? By 2044, people with skin of color (SOC) will make up the majority of the U.S. population—but dermatology still lags behind in addressing their unique needs.…
Read More
Acne Treatment Without the Dry-Out: Clascoterone Cream 1% Proves Gentle on the Skin Barrier Topical acne meds often come with an unfortunate side effect: dry, irritated skin that leaves patients…
Read More
April Issue Must-Read! Hidradenitis suppurativa (HS) isn’t just painful—it’s deeply isolating. And new data reveals why: the majority of people living with HS don’t feel heard, treated, or informed. In a…
Read More
Did you miss this #acneceuticals article from April’s issue? What if your acne routine could be smarter, more personalized—and actually stick? Say hello to the new acne algorithm that’s changing…
Read More
Beyond the Granuloma: Rethinking Treatment Strategies for Generalized Granuloma Annulare Long considered a therapeutic challenge, generalized granuloma annulare (GGA) continues to defy many conventional treatment approaches. While topical steroids may…
Read More
Explore JDDonline If you’re on the hunt for expert-led, handpicked resources on atopic dermatitis, you’re in the right place. Whether you're brushing up on the latest treatment insights or looking…
Read More
Rituximab in the Treatment of Epidermolysis Bullosa Acquisita: A Systematic Review of the Literature
Could Rituximab Be the Key to Managing Epidermolysis Bullosa Acquisita? Epidermolysis bullosa acquisita (EBA) is a rare and often debilitating autoimmune blistering disease that remains notoriously difficult to manage. While…
Read More
A Breakthrough Approach to Aging Skin: Can This Cream Combat Dermatoporosis? As skin ages, it becomes fragile, thin, and prone to bruising - a condition known as dermatoporosis, which is…
Read More
Are Atopic Dermatitis Clinical Trials Becoming More Inclusive? Atopic dermatitis (AD) affects over 31 million people in the U.S., disproportionately impacting racial and ethnic minorities who often experience greater disease…
Read More
